Cargando…

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter

BACKGROUND: To assess the clinical validity of controlled attenuation parameter (CAP) in the diagnosis of hepatic steatosis in a series of overweight or obese children by using the imperfect gold standard methodology. METHODS: Consecutive children referred to our institution for auxological evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraioli, Giovanna, Calcaterra, Valeria, Lissandrin, Raffaella, Guazzotti, Marinella, Maiocchi, Laura, Tinelli, Carmine, De Silvestri, Annalisa, Regalbuto, Corrado, Pelizzo, Gloria, Larizza, Daniela, Filice, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418679/
https://www.ncbi.nlm.nih.gov/pubmed/28472948
http://dx.doi.org/10.1186/s12876-017-0617-6
_version_ 1783234087395262464
author Ferraioli, Giovanna
Calcaterra, Valeria
Lissandrin, Raffaella
Guazzotti, Marinella
Maiocchi, Laura
Tinelli, Carmine
De Silvestri, Annalisa
Regalbuto, Corrado
Pelizzo, Gloria
Larizza, Daniela
Filice, Carlo
author_facet Ferraioli, Giovanna
Calcaterra, Valeria
Lissandrin, Raffaella
Guazzotti, Marinella
Maiocchi, Laura
Tinelli, Carmine
De Silvestri, Annalisa
Regalbuto, Corrado
Pelizzo, Gloria
Larizza, Daniela
Filice, Carlo
author_sort Ferraioli, Giovanna
collection PubMed
description BACKGROUND: To assess the clinical validity of controlled attenuation parameter (CAP) in the diagnosis of hepatic steatosis in a series of overweight or obese children by using the imperfect gold standard methodology. METHODS: Consecutive children referred to our institution for auxological evaluation or obesity or minor elective surgery were prospectively enrolled. Anthropometric and biochemical parameters were recorded. Ultrasound (US) assessment of steatosis was carried out using ultrasound systems. CAP was obtained with the FibroScan 502 Touch device (Echosens, Paris, France). Pearson’s or Spearman’s rank correlation coefficient were used to test the association between two study variables. Optimal cutoff of CAP for detecting steatosis was 249 dB/m. The diagnostic performance of dichotomized CAP, US, body mass indexes (BMI), fatty liver index (FLI) and hepatic steatosis index (HSI) was analyzed using the imperfect gold standard methodology. RESULTS: Three hundred five pediatric patients were enrolled. The data of both US and CAP were available for 289 children. Steatosis was detected in 50/289 (17.3%) children by US and in 77/289 (26.6%) by CAP. A moderate to good correlation was detected between CAP and BMI (r = 0.53), FLI (r = 0.55) and HSI (r = 0.56). In obese children a moderate to good correlation between CAP and insulin levels (r = 0.54) and HOMA-IR (r = 0.54) was also found. Dichotomized CAP showed a performance of 0.70 (sensitivity, 0.72 [0.64–0.79]; specificity, 0.98 [0.97–0.98], which was better than that of US (performance, 0.37; sensitivity, 0.46 [0.42–0.50]; specificity, 0.91 [0.89–0.92]), BMI (performance, 0.22; sensitivity, 0.75 [0.73–0.77]; specificity, 0.57 [0.55–0.60]) and FLI or HSI. CONCLUSIONS: For the evaluation of liver steatosis in children CAP performs better than US, which is the most widely used imaging technique for screening patients with a suspicion of liver steatosis. A cutoff value of CAP of 249 dB/m rules in liver steatosis with a very high specificity.
format Online
Article
Text
id pubmed-5418679
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54186792017-05-08 Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter Ferraioli, Giovanna Calcaterra, Valeria Lissandrin, Raffaella Guazzotti, Marinella Maiocchi, Laura Tinelli, Carmine De Silvestri, Annalisa Regalbuto, Corrado Pelizzo, Gloria Larizza, Daniela Filice, Carlo BMC Gastroenterol Research Article BACKGROUND: To assess the clinical validity of controlled attenuation parameter (CAP) in the diagnosis of hepatic steatosis in a series of overweight or obese children by using the imperfect gold standard methodology. METHODS: Consecutive children referred to our institution for auxological evaluation or obesity or minor elective surgery were prospectively enrolled. Anthropometric and biochemical parameters were recorded. Ultrasound (US) assessment of steatosis was carried out using ultrasound systems. CAP was obtained with the FibroScan 502 Touch device (Echosens, Paris, France). Pearson’s or Spearman’s rank correlation coefficient were used to test the association between two study variables. Optimal cutoff of CAP for detecting steatosis was 249 dB/m. The diagnostic performance of dichotomized CAP, US, body mass indexes (BMI), fatty liver index (FLI) and hepatic steatosis index (HSI) was analyzed using the imperfect gold standard methodology. RESULTS: Three hundred five pediatric patients were enrolled. The data of both US and CAP were available for 289 children. Steatosis was detected in 50/289 (17.3%) children by US and in 77/289 (26.6%) by CAP. A moderate to good correlation was detected between CAP and BMI (r = 0.53), FLI (r = 0.55) and HSI (r = 0.56). In obese children a moderate to good correlation between CAP and insulin levels (r = 0.54) and HOMA-IR (r = 0.54) was also found. Dichotomized CAP showed a performance of 0.70 (sensitivity, 0.72 [0.64–0.79]; specificity, 0.98 [0.97–0.98], which was better than that of US (performance, 0.37; sensitivity, 0.46 [0.42–0.50]; specificity, 0.91 [0.89–0.92]), BMI (performance, 0.22; sensitivity, 0.75 [0.73–0.77]; specificity, 0.57 [0.55–0.60]) and FLI or HSI. CONCLUSIONS: For the evaluation of liver steatosis in children CAP performs better than US, which is the most widely used imaging technique for screening patients with a suspicion of liver steatosis. A cutoff value of CAP of 249 dB/m rules in liver steatosis with a very high specificity. BioMed Central 2017-05-04 /pmc/articles/PMC5418679/ /pubmed/28472948 http://dx.doi.org/10.1186/s12876-017-0617-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ferraioli, Giovanna
Calcaterra, Valeria
Lissandrin, Raffaella
Guazzotti, Marinella
Maiocchi, Laura
Tinelli, Carmine
De Silvestri, Annalisa
Regalbuto, Corrado
Pelizzo, Gloria
Larizza, Daniela
Filice, Carlo
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
title Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
title_full Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
title_fullStr Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
title_full_unstemmed Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
title_short Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
title_sort noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418679/
https://www.ncbi.nlm.nih.gov/pubmed/28472948
http://dx.doi.org/10.1186/s12876-017-0617-6
work_keys_str_mv AT ferraioligiovanna noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT calcaterravaleria noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT lissandrinraffaella noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT guazzottimarinella noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT maiocchilaura noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT tinellicarmine noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT desilvestriannalisa noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT regalbutocorrado noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT pelizzogloria noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT larizzadaniela noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter
AT filicecarlo noninvasiveassessmentofliversteatosisinchildrentheclinicalvalueofcontrolledattenuationparameter